e-learning
resources
Virtual 2020
Pre-Congress Content
News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inflammatory bowel diseases in COPD patients.
A. Berdyugina (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), I. Belova (Barnaul, Russian Federation)
Source:
Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Session:
News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Session type:
E-poster session
Number:
1291
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Berdyugina (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), I. Belova (Barnaul, Russian Federation). Inflammatory bowel diseases in COPD patients.. 1291
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
A 41-year-old male with cough productive of yellow sputum and worsening breathlessness
Related content which might interest you:
Functional and inflammatory bowel diseases in patients with COPD
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Functional and inflammatory bowel diseases in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Inflammatory bowel diseases and the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 55s
Year: 2006
Inflammatory bowel diseases, chronic liver diseases and the lung
Source: Eur Respir J 2016; 47: 638-650
Year: 2016
Lung function in children with inflammatory bowel diseases
Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Year: 2007
Inflammatory bowel disease and risk of mortality in COPD
Source: Eur Respir J 2016; 47:1357-1364
Year: 2016
Pulmonary involvement of inflammatory bowel disease in children and adult patients
Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders
Year: 2010
Inflammatory bowel diseases and respiratory manifestations
Source: International Congress 2017 – Respiratory manifestations of gastrointestinal diseases
Year: 2017
Increased incidence of inflammatory bowel disease in Québec residents with airway diseases
Source: Eur Respir J 2015; 45: 962-968
Year: 2015
Characteristics of inflammatory bowel diseases-associated interstitial lung diseases
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Airway and lung involvement in inflammatory bowel disease
Source: Eur Respir Monogr 2019; 86: 228-261
Year: 2019
Inflammatory markers in COPD patients with and without cachexia
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Bronchial hyperreactivity in patients with inflammatory bowel disease
Source: Eur Respir J 2003; 22: Suppl. 45, 480s
Year: 2003
Bronchiectasis associated with inflammatory bowel disease
Source: Eur Respir Mon 2011; 52: 163-177
Year: 2011
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Inflammatory markers in relation to cachexia in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept